In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma

Urology

Volumn 67, Issue 5, 2006, Pages 1093-1098

  Tian, Jun Qiang ^a   Wang, Zhi Ping ^a   Rodriguez, Ronald ^b   Fu, Jun Sheng ^a   Lu, Jian Zhong ^a   Ma, Bao Liang ^a  

^a LANZHOU UNIVERSITY   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; LIPOSOME; MESSENGER RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; APOPTOSIS REGULATORY PROTEIN; MEMBRANE PROTEIN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXICITY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; WESTERN BLOTTING; BIOSYNTHESIS; CELL LINE; CYTOTOXICITY TEST; GENE VECTOR; GENETICS; IMMUNOLOGY; PROTEIN SYNTHESIS; TUMOR CELL LINE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, RENAL CELL; CELL LINE; CELL LINE, TUMOR; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; GENETIC VECTORS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-2; LYMPHOCYTES, TUMOR-INFILTRATING; MEMBRANE GLYCOPROTEINS; PROTEIN BIOSYNTHESIS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646823935     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.11.030     Document Type: Article

References (20)

1. Mancuso A., and Sternberg C.N. New treatments for metastatic kidney cancer. Can J Urol 12 suppl 1 (2005) 66-70
2. Dillman R., Schiltz P., DePriest C., et al. Tumor-infiltrating lymphocytes and interleukin-2. dose and schedules of administration in the treatment of metastatic cancer. Cancer Biother Radiopharm 19 (2004) 730-737
3. Gardini A., Ercolani G., Riccobon A., et al. Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases. 5-year analysis. J Surg Oncol 87 (2004) 46-52
4. Pitti R.M., Marsters S.A., Ruppert S., et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271 (1996) 12687-12690
5. Walczak H., Miller R.E., Ariail K., et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5 (1999) 157-163
6. Mizutani Y., Bonavida B., Koishihara Y., et al. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum (II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody. Cancer Res 55 (1995) 590-596
7. Tsunoda T., Tanimura H., Yamaue H., et al. Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4. Br J Cancer 74 (1996) 1085-1089
8. Akiyama H., Tanaka T., Itakura H., et al. Inhibition of ocular angiogenesis by an adenovirus carrying the human von Hippel-Lindau tumor-suppressor gene in vivo. Invest Ophthalmol Vis Sci 45 (2004) 1289-1296
9. Suzuki K., Hino M., Kutsuna H., et al. Selective activation of p38 mitogen-activated protein kinase cascade in human neutrophils stimulated by IL-1beta. J Immunol 167 (2001) 5940-5947
10. Lai R., McDonnell T.J., O'Connor S.L., et al. Establishment and characterization of a new mantle cell lymphoma cell line, Mino. Leuk Res 26 (2002) 849-855
11. Fliss-Jaber L., Houissa-Kastally R., Bouzouita K., et al. Cytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patients. BMC Cancer 4 (2004) 68-77
12. + T cells against autologous tumor cells. Jpn J Cancer Res 86 (1995) 854-860
13. Cohly H., Jenkins J., Skelton T., et al. Fructose-1,6-diphosphate suppresses T-lymphocyte proliferation, promotes apoptosis and inhibits interleukins-1, 6, beta-actin mRNAs, and transcription factors expression. Immunol Invest 33 (2004) 407-421
14. Steinberg T., Ohlschlager P., Sehr P., et al. Modification of HPV 16 E7 genes. correlation between the level of protein expression and CTL response after immunization of C57BL/6 mice. Vaccine 23 (2005) 1149-1157
15. Jeremias I., Herr I., Boehler T., et al. TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Eur J Immunol 28 (1998) 143-152
16. Kayagaki N., Yamaguchi N., Nakayama M., et al. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J Immunol 15 (1999) 1906-1913
17. Ashkenazi A., and Dixit V.M. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11 (1999) 255-260
18. Griffith T.S., and Lynch D.H. TRAIL. a molecule with multiple receptors and control mechanism. Curr Opin Immunol 10 (1998) 559-563
19. Yanelli J.R., Hyatt C., McConnell S., et al. Growth of tumor-infiltrating lymphocytes from human solid cancers. summary of a 5-year experience. Int J Cancer 65 (1996) 413-421
20. Ashkenazi A., Pai R.C., Fong S., et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104 (1999) 155-162